TransMedics Targets $2B Opportunity With Kidney Push, European Expansion
MarketBeat
TransMedics Group (NASDAQ:TMDX) outlined its growth strategy at Canaccord Genuity’s 46th Annual Global Growth Conference, highlighting investments in kidney transplantation, European expansion, next-generation technology and broader adoption in heart and lung transplantation.
Waleed Hassanein, Tran
NASDAQ:TMDX